Newborn Hearing Screening Results of Infants Born To Mothers Who Had COVID-19 Disease During Pregnancy: A Retrospective Cohort Study. 2022

Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
TOBB Economy and Technology University Hospital, Department of Obstetrics and Gynecology, Ankara, Turkey.

Viral infections are known to be a risk factor for neonatal hearing loss. COVID-19 infection has been reported to affect hearing test results in one small sample sized study. We aimed to investigate the incidence the risk of neonatal hearing loss in infants of mothers who had COVID-19 infection during pregnancy, regarding their trimesters, by evaluating the neonatal hearing screening results. In this retrospective case-control study, neonatal hearing test results of 458 women with a history of COVID-19 infection in pregnancy were compared with 339 women who gave birth before the pandemic. Data of pregnant women who attended the COVID-19 outpatient clinic of the emergency service of a tertiary pandemic hospital and who had confirmed infection with a reverse transcriptase-polymerase chain reaction (RT-PCR) test were determined from the hospital's records and their neonatal hearing screening results were analyzed from the national database. Neonates born before <34 weeks, and with reported risk factors in the database such as congenital anomaly or known TORCH infection during pregnancy were excluded. The screening tests, Automated Auditory Brainstem Response or Transient Evoked Otoacoustic Emission (TEOAE), were used for screening, and patients who failed the first screening were reevaluated at least 2 weeks apart with a second screening. The incidence of failed second screening was 1.3% in the COVID-19 group and 2.9% in controls, and no significant difference was observed between the two groups according to the final screening results on the second test. Among the 458 mothers, 8 were infected in first trimester, 126 in second trimester, 127 in third trimester but did not deliver within 15 days after infection and 197 were positive at birth. Six neonates in the infected group failed the second screening (3 [2.4%] in the second trimester, 1 [0.8%] third trimester, and 2 [1.0%] positive at birth). COVID-19 infection during pregnancy was not found to be a risk factor for hearing loss, according to the newborn hearing screening results.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009035 Mothers Female parents, human or animal. Mothers' Clubs,Club, Mothers',Clubs, Mothers',Mother,Mother Clubs,Mother's Clubs,Mothers Clubs,Mothers' Club
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D006320 Hearing Tests Part of an ear examination that measures the ability of sound to reach the brain. Hearing in Noise Test,Quick Speech-in Noise Test (QuickSIN),Real Ear Measurement,Speech in Noise Hearing Test,Ear Measurement, Real,Ear Measurements, Real,Hearing Test,Measurement, Real Ear,Measurements, Real Ear,Quick Speech in Noise Test (QuickSIN),Real Ear Measurements,Test, Hearing,Tests, Hearing
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
March 1980, Voprosy okhrany materinstva i detstva,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
December 2011, Jornal da Sociedade Brasileira de Fonoaudiologia,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
January 2020, Neonatology,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
March 2023, European journal of pediatrics,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
June 2022, Cureus,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
September 2009, American journal of obstetrics and gynecology,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
May 2018, Paediatrics & child health,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
March 1995, BMJ (Clinical research ed.),
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
November 2000, Anales espanoles de pediatria,
Z Asli Oskovi-Kaplan, and A Seval Ozgu-Erdinc, and Gul Nihal Buyuk, and U Yasemin Sert-Dinc, and Cavide Ali-Algan, and Bariş Demir, and Dilek Sahin, and H Levent Keskin, and Cüneyt Tayman, and Özlem Moraloglu-Tekin
January 2021, Revista gaucha de enfermagem,
Copied contents to your clipboard!